Yangtze River Pharmaceutical is a state owned enterprise or a private enterprise

Private Sector.

Zijiang Pharmaceutical Group is a private enterprise.

In 2019, China's top 500 manufacturing enterprises ranked 107th. On March 18, 2020, Yangtze River Pharmaceutical Group.

Founded in 1971, Yangtze River Pharmaceutical Group is a large-scale pharmaceutical enterprise group in China that combines production, education and research, and integrates science, industry and trade.

It's a private company. Founded in 1971, Yangtze River Pharmaceutical Group is a national large-scale pharmaceutical enterprise group that combines production, education and research, and integrates science, industry and trade.

Yangtze River Pharmaceutical is a state-owned enterprise or a private enterprise

With Yangtze River Pharmaceutical Group as the core enterprise, the group has more than 10 subsidiaries in Taizhou, Beijing, Shanghai, Nanjing, Guangzhou, Chengdu and other places, with a 10,000-ton traditional Chinese medicine extraction production base.

As one of the first batch of "innovative enterprises" named by the Ministry of Science and Technology of the People's Republic of China, Yangtze River Pharmaceutical actively promotes the transformation from "manufacturing" to "creation", and strives to shoulder its own mission in the great practice of building an innovative country.

Yangtze River Pharmaceutical Co., Ltd. has formed a product group with more than 10 series, 20 dosage forms and more than 100 specifications of Chinese and Western medicines, covering antibiotics, digestive system drugs, circulatory system drugs, antineoplastic drugs, antipyretic analgesics and other fields.

No. Founded in 1971, Yangtze River Pharmaceutical Group is a large-scale pharmaceutical enterprise group in China that combines production, education and research, and integrates science, industry and trade. The headquarters is located in Taizhou City, Jiangsu Province, a famous city on the Yangtze River Delta and a famous city in the Yangtze River Delta.

On July 5, 2007, at the press conference held in Nanjing on the adjustment of the province's industrial and commercial structure, the development of major industrial industries in 2006, the top 100 enterprises in operating income and the top 100 private enterprises in operating income, Yangtze River Pharmaceutical Group was shortlisted in the list of top 100 enterprises (groups) and top 100 private enterprises with an operating income of 100 million yuan, ranking 45th and 17th respectively.

Yangzhou Yangzijiang Investment and Development Group Co., Ltd. was established on December 18, 2003, is a wholly state-owned enterprise group funded by Yangzhou City and granted the qualification of state-owned assets investment, with a registered capital of 100 million yuan. Next to the reeds.

It is mainly engaged in the operation, management, transfer, investment, enterprise trusteeship, asset restructuring and other businesses of state-owned assets within the scope of the municipal authorization. As of the end of June 2016, the group's total assets reached 7.2 billion yuan, net assets reached 2.7 billion yuan, and there were 4,500 employees.